SAREPTA THERAPEUTICS INC (SRPT) Stock Price & Overview
NASDAQ:SRPT • US8036071004
Current stock price
The current stock price of SRPT is 22.24 USD. Today SRPT is up by 1.55%. In the past month the price increased by 24.01%. In the past year, price decreased by -57.08%.
SRPT Key Statistics
- Market Cap
- 2.335B
- P/E
- N/A
- Fwd P/E
- 7.36
- EPS (TTM)
- -6.65
- Dividend Yield
- N/A
SRPT Stock Performance
SRPT Stock Chart
SRPT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SRPT. When comparing the yearly performance of all stocks, SRPT is a bad performer in the overall market: 90.23% of all stocks are doing better.
SRPT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SRPT. Both the profitability and financial health of SRPT have multiple concerns.
SRPT Earnings
On February 25, 2026 SRPT reported an EPS of -3.93 and a revenue of 442.93M. The company missed EPS expectations (-213.05% surprise) and beat revenue expectations (10.8% surprise).
SRPT Forecast & Estimates
33 analysts have analysed SRPT and the average price target is 30.27 USD. This implies a price increase of 36.12% is expected in the next year compared to the current price of 22.24.
For the next year, analysts expect an EPS growth of 145.42% and a revenue growth -18.84% for SRPT
SRPT Groups
Sector & Classification
SRPT Financial Highlights
Over the last trailing twelve months SRPT reported a non-GAAP Earnings per Share(EPS) of -6.65. The EPS decreased by -391.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.3% | ||
| ROE | -62.55% | ||
| Debt/Equity | 0.73 |
SRPT Ownership
SRPT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.34 | 374.127B | ||
| AMGN | AMGEN INC | 15.58 | 188.572B | ||
| GILD | GILEAD SCIENCES INC | 16.11 | 175.711B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.98 | 112.769B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.41 | 81.989B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.82 | 43.4B | ||
| INSM | INSMED INC | N/A | 34.527B | ||
| NTRA | NATERA INC | N/A | 29.881B | ||
| BIIB | BIOGEN INC | 10.94 | 26.402B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.26 | 25.496B | ||
| MRNA | MODERNA INC | N/A | 20.576B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.173B | ||
| INCY | INCYTE CORP | 12.69 | 19.083B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SRPT
Company Profile
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Company Info
IPO: 1997-06-04
SAREPTA THERAPEUTICS INC
215 First Street, Suite 415
Cambridge MASSACHUSETTS 02142 US
CEO: Douglas S. Ingram
Employees: 835
Phone: 16172744000
SAREPTA THERAPEUTICS INC / SRPT FAQ
What does SAREPTA THERAPEUTICS INC do?
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Can you provide the latest stock price for SAREPTA THERAPEUTICS INC?
The current stock price of SRPT is 22.24 USD. The price increased by 1.55% in the last trading session.
What is the dividend status of SAREPTA THERAPEUTICS INC?
SRPT does not pay a dividend.
What is the ChartMill technical and fundamental rating of SRPT stock?
SRPT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is SAREPTA THERAPEUTICS INC (SRPT) expected to grow?
The Revenue of SAREPTA THERAPEUTICS INC (SRPT) is expected to decline by -18.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is SAREPTA THERAPEUTICS INC worth?
SAREPTA THERAPEUTICS INC (SRPT) has a market capitalization of 2.33B USD. This makes SRPT a Mid Cap stock.